Radiotherapy and chemotherapy for elderly patients with stage I-II unresected lung cancer

European Respiratory Journal

Volumn 40, Issue 4, 2012, Pages 957-964

  Wisnivesky, Juan P ^a   Bonomi, Marcelo ^a   Lurslurchachai, Linda ^a   Mhango, Grace ^a   Halm, Ethan A ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Chemotherapy; Early stage; Lung cancer; Radiation; Treatment; Unresected

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DEHYDRATION; DRUG FEVER; FEMALE; HUMAN; HUMAN TISSUE; INFECTION; INOPERABLE CANCER; INTERMETHOD COMPARISON; KIDNEY DISEASE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NAUSEA; NEUTROPENIA; POPULATION RESEARCH; PRIORITY JOURNAL; SURVIVAL RATE; THROMBOCYTOPENIA; VOMITING;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84867115851     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00176911     Document Type: Article

References (42)

1. Bach PB, Cramer LD, Warren JL, et al. Racial differences in the treatment of early-stage lung cancer. N Engl J Med 1999; 341: 1198-1205. (Pubitemid 29480659)
2. Wisnivesky JP, Halm EA. Sex differences in lung cancer survival: do tumors behave differently in elderly women? J Clin Oncol 2007; 25: 1705-1712. (Pubitemid 46797951)
3. Wisnivesky JP, Halm E, Bonomi M, et al. Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer. Am J Respir Crit Care Med, 181: 264-269.
4. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer. Version I. 2010. Fort Washington, National Comprehensive Cancer Network, 2009. Available from www.nccn.org/ professionals/physician-gls/pdf/nscl.pdf
5. Wisnivesky JP, Bonomi M, Henschke C, et al. Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer. Chest 2005; 128: 1461-1467. (Pubitemid 41324433)
6. Raz DJ, Zell JA, Ou SH, et al. Natural history of stage I non-small cell lung cancer: implications for early detection. Chest 2007; 132: 193-199. (Pubitemid 47068221)
7. Auperin A, Le Pechoux C, Pignon JP, et al. Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients. Ann Oncol 2006; 17: 473-483. (Pubitemid 43329586)
8. Auperin A, Le Pechoux C, Rolland E, et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J ClinOncol 2010; 28: 2181-2190.
9. Abratt RP, Willcox PA, Hewitson RH. Radical irradiation of localized inoperable lung cancer with concurrent chemotherapy and misonidazole. a phase I/II study. Eur J Cancer Clin Oncol 1987; 23: 1081-1082.
10. Gregor A, Macbeth FR, Paul J, et al. Radical radiotherapy and chemotherapy in localized inoperable non-small-cell lung cancer: a randomized trial. J Natl Cancer Inst 1993; 85: 997-999.
11. Kyasa MJ, Jazieh AR. Characteristics and outcomes of patients with unresected early-stage non-small cell lung cancer. South Med J 2002; 95: 1149-1152. (Pubitemid 35244833)
12. Horner MJ, Ries LAG, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2006. Bethesda, National Cancer Institute, http:// seer.cancer.gov/csr/ 1975-2006/ Based on November 2008 SEER data submission; posted to the SEER website 2009. Date last accessed: June 19, 2012.
13. Warren JL, Klabunde CN, Schrag D, et al. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002; 40: Suppl. 8, IV-3-18.
14. Earle CC, Tsai JS, Gelber RD, et al. Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis. J Clin Oncol 2001; 19: 1064-1070. (Pubitemid 32176282)
15. Park CH, Bonomi M, Cesaretti J, et al. Effect of radiotherapy planning complexity on survival of elderly patients with unresected localized lung cancer. Int J Radiat Oncol Biol Phys 2011; 81: 706-711.
16. Klabunde CN, Potosky AL, Legler JM, et al. Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000; 53: 1258-1267. (Pubitemid 32007842)
17. Klabunde CN, Legler JM, Warren JL, et al. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol 2007; 17: 584-590. (Pubitemid 47096709)
18. Goldstraw P, ed. Staging Manual in Thoracic Oncology. Orange Park, Editorial Rx Press, 2009.
19. Lathan CS, Neville BA, Earle CC. The effect of race on invasive staging and surgery in non-small-cell lung cancer. J Clin Oncol 2006; 24: 413-418. (Pubitemid 46630461)
20. Cooper GS, Virnig B, Klabunde CN, et al. Use of SEER-Medicare data for measuring cancer surgery. Med Care 2002; 40: Suppl. 8, IV-43-8.
21. Virnig BA, Warren JL, Cooper GS, et al. Studying radiation therapy using SEER-Medicare-linked data. Med Care 2002; 40: Suppl. 8, IV-49-54.
22. Goldsmith B, Cesaretti J, Wisnivesky JP. Radiotherapy planning complexity and survival after treatment of advanced stage lung cancer in the elderly. Cancer 2009; 115: 4865-4873.
23. Warren JL, Harlan LC, Fahey A, et al. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care 2002; 40: Suppl. 8, IV-55-61.
24. Wisnivesky JP, Smith CB, Packer S, et al. Survival and risk of adverse events in older patients receiving postoperative adjuvant chemotherapy for resected stages II-IIIA lung cancer: observational cohort study. BMJ 2011; 343: d4013.
25. Du XL, Osborne C, Goodwin JS. Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer. J Clin Oncol 2002; 20: 4636-4642. (Pubitemid 36025279)
26. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997; 127: 757-763. (Pubitemid 27446562)
27. Wei L, Lin D, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc 1989; 84: 1065-1073.
28. Sigel K, Bonomi M, Packer S, et al. Effect of age on survival of clinical stage I non-small-cell lung cancer. Ann Surg Oncol 2009; 16: 1912-1917.
29. Qiao X, Tullgren O, Lax I, et al. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 2003; 41: 1-11. (Pubitemid 36765477)
30. Zimmermann FB, Bamberg M, Molls M, et al. Radiation therapy alone in early stage non-small cell lung cancer. Semin Surg Oncol 2003; 21: 91-97. (Pubitemid 37237418)
31. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010; 303: 1070-1076.
32. Fernando HC, De Hoyos A, Landreneau RJ, et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg 2005; 129: 639-644. (Pubitemid 40311325)
33. Atagi S, Kawahara M, Tamura T, et al. Standard thoracic radiotherapy with or without concurrent daily low-dose carbo-platin in elderly patients with locally advanced non-small cell lung cancer: a phase III trial of the Japan Clinical Oncology Group (JCOG9812). Jpn J Clin Oncol 2005; 35: 195-201. (Pubitemid 40796853)
34. Movsas B, Scott C, Sause W, et al. The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies. Int J Radiat Oncol Biol Phys 1999; 45: 1143-1149.
35. Werner-Wasik M, Scott C, Cox JD, et al. Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival. Int J Radiat Oncol Biol Phys 2000; 48: 1475-1482.
36. Schild SE, Stella PJ, Geyer SM, et al. The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol 2003; 21: 3201-3206. (Pubitemid 46606250)
37. Pritchard RS, Anthony SP. Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis. Ann Intern Med 1996; 125: 723-729. (Pubitemid 126450359)
38. Marino P, Preatoni A, Cantoni A. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis. Cancer 1995; 76: 593-601.
39. Firat S, Bousamra M, Gore E, et al. Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002; 52: 1047-1057. (Pubitemid 34219026)
40. Asmis TR, Ding K, Seymour L, et al. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials. J Clin Oncol 2008; 26: 54-59.
41. Atagi S, Kawahara M, Ogawara M, et al. Phase II trial of daily low-dose carboplatin and thoracic radiotherapy in elderly patients with locally advanced non-small cell lung cancer. Jpn J Clin Oncol 2000; 30: 59-64.
42. Langer C, Scott C, Byhardt R, et al. Effect of advanced age on outcome in radiation therapy oncology group studies of locally advanced NSCLC (LA-NSCLC). Lung Cancer 2000; 29: Abstract 40.